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Abstract
Background: Malnutrition is a problem for many older people recovering from a hip and other major fractures.
Oral supplementation with high calorie high protein nutrients is a simple intervention that may help older people
with fractures to improve their recovery in terms of rehabilitation time, length of hospital stay and mortality. This
paper reports a pilot study to test the feasibility of a trial initiated in a hospital setting with an oral supplement to
older people with recent fractures.
Method: A randomized controlled trial with 44 undernourished participants admitted to a hospital following a
fracture. The intervention group (n = 23) received a high calorie high protein supplement for forty days in addition
to their diet of choice. The control group (n = 21) received high protein milk during their hospital stay in addition
to their diet of choice and their usual diet when discharged from hospital.
Results: All participants were women and their mean age was 85.3 (± 6.1) years. Twenty nine (65%) participants had
a hip fracture. At baseline no differences were measured between the two groups regarding their nutritional status,
their cognitive ability or their abilities in activities of daily living. There were no significant differences between the
intervention and control group with reference to nutritional or functional parameters at 40 day and 4 month follow-
ups. Median length of stay in hospital was 18.0 days, with 12 participants being readmitted for a median of 7.0 days.
Conclusion: It is feasible to perform a randomised trial in a hospital and community setting to test the effect of an
oral high energy high protein supplement for older people. Due to the limited number of participants and
incomplete adherence with use of the supplements no conclusion can be drawn about the efficacy or
effectiveness of this intervention.
Background
The risk of malnutrition is increased in older people and
it has been shown to have important effects on recovery
in a broad range of conditions [1]. Malnutrition has been
associated with impaired immune response, impaired
muscle and respiratory function, delayed wound healing,
overall increased complications, longer rehabilitation,
greater length of hospital stay and increased mortality
[2]. Older people with fractures are a particularly
vulnerable group. Not only is there a high chance of
these patients being malnourished upon admission [3],
but a further decline in their nutritional state due to sur-
gery and hospitalization is a serious risk [4]. Various
initiatives, of which the majority includes supplementa-
tion, have been undertaken to help improve the nutri-
tional state for those older people being admitted to the
hospital [1,5]. However, the effects so far are question-
able. The current Cochrane Review on nutritional sup-
plementation for hip fracture aftercare in older people
concluded that the there is only weak evidence for the
effectiveness of protein and energy feeds, and more high
quality randomized trials are needed [6]. No clear
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efit more than those who are not malnourished. It has
been suggested that low compliance to oral supplementa-
tion may be a problem due to low palatability [6]. On the
other hand, advantages of oral supplements are that the
intervention itself is rather simple, takes only a short per-
iod of time, and is likely to be perceived as a relevant
intervention by older people recovering from a fracture.
These advantages should help improve compliance to the
intervention [7-10].
The objectives of this pilot study are, firstly, to study
the feasibility of a randomized trial initiated in the hospi-
tal setting. Secondly, to test the effectiveness of oral sup-
plementation to malnourished older people with a
fracture. We investigate the effectiveness of a high cal-
orie, high protein nutritional supplement in terms of
changes in recovery rate as measured by abilities in activ-
ities of daily living (ADL), and nutritional status.
Method
Participants
Patients admitted to Hornsby Ku-ring-gai hospital (a gen-
eral hospital in Northern Sydney, Australia) from February
2000 to January 2003 with hip or other fractures were
asked to participate within 5 days of admission. Due to
limited funding and staff changes not all patients were
approached, but approximately 10% to 20% of the patients
screened satisfied the inclusion criteria. Inclusion criteria
included: female aged over 70 with moderate or severe
protein energy malnutrition (PEM). PEM was defined as
moderate if the mid-upper arm circumference (MUAC)
was less than the 10th percentile for age and gender, or if
the pre-surgery serum albumin concentration was lower
than or equal to 35 g/L [11]. Malnutrition was considered
severe if both these criteria were met. Patients were
excluded if they had diagnosed metastatic cancer, chronic
renal failure or hepatic failure. After screening for their
nutritional status, and obtaining informed consent from
patients themselves or their person responsible, patients
were randomized to either a supplement or usual care
group. This study was approved by the Research Ethics
committee of the Hornsby Ku-ring-gai Hospital.
The randomization sequence was derived from a ran-
dom numbers table and the allocation was recorded on
a card sealed in a sequentially numbered opaque envel-
ope. Randomization was stratified for hip or other frac-
ture, and extent of undernutrition. Once informed
consent was given, the research nurse opened the next
numbered envelope and informed the participant of the
group to which they had been randomized.
Intervention
The participants in the intervention group were asked to
drink one pack of supplement per day from when oral
intake was resumed after surgery, or from enrolment in
subjects who had no surgical treatment. The supplemen-
tation was to be continued for forty days on a once daily
basis. During the trial there was a change in supplement
because the Sustagen Hospital Plus originally used in the
study was no longer available in Australia. This change
occurred after the first 12 months of recruitment when
11 participants had been enrolled. After taste testing and
nutrient composition comparisons, Novasource was
agreed to be acceptable and replaced Sustagen Hospital
Plus (nutrients details of the supplements can be found
in Additional File 1). If during the trial period of 40 days
participants were discharged from the hospital they were
given the remaining nutritional supplements with
instructions to keep drinking them as discussed. Partici-
pants in the control group were given a high protein diet
(with high protein milk) during their hospital stay
because this was standard treatment at the study hospital
and it was judged not to be ethical to withdraw this.
After discharge they could follow their normal diet. Both
groups received the same rehabilitation programs.
Outcome measurements
Measurements took place at 1) baseline; which was after
admission to hospital and before surgery, 2) after 40
days and 3) after 4 months. Baseline measures included
weight, height, mid upper-arm circumference (MUAC),
grip strength, serum albumin (g/L), activities of daily liv-
ing as assessed by the Barthel Index [12], Short Portable
Mental Status Questionnaire (SPMSQ) [13] to assess
participant’s cognitive status, and the Charlson Index to
evaluate the presence of co morbidities [14]. The partici-
pant’s knee height was used to calculate the estimated
actual height so that body mass index (BMI) could be
calculated [15].
Weight and height at baseline were obtained via self-
report, or from the family carer, if possible. Although, it
was realized that self-report of weight may not be the
most accurate method this way was considered most
practical [16,17]. Mid upper-arm circumference (MUAC)
to the nearest millimeter was measured in the non domi-
nant arm using a fiberglass tape at baseline. MUAC
norms reported by Falciglia et al. were used as a refer-
ence when assessing MUAC measurement [18]. Grip
strength in the dominant arm was measured with a
hand-grip dynamometer (Jamar), using three trials with
the highest reading recorded [19]. The Barthel Index was
used to assess disability status and includes 15 self-care,
sphincter-control, and mobility factors. A Barthel score
of 40 or less is defined as very severely dependent; score
of 60 or less defined as markedly dependent while score
of 61-80 demonstrates less need for assistance [12].
The measurements were repeated at 40 days and 4
months follow up by a research nurse who was masked
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after 40 days and after 4 months the gait speed of parti-
cipants was measured. The time required for subjects to
walk 2.44 m was used to calculate gait speed [20].
Details of complications and length of hospital stay
were obtained from the subjects’ medical records. Ascer-
tainment of these complications was completed by the
research nurse. Readmission to hospital and mortality
were also recorded.
Statistical analysis
The data analysis was performed using SPSS 16.0 (SPSS
Inc., Chicago, IL, USA). P < 0.05 was considered statisti-
cally significant. For descriptive purposes, mean values
and standard deviations were used for normal distribu-
ted data, and range and medians for data with a skewed
distribution. For comparison between groups, student’s
t-test was used or a Mann-Whitney U-test. For compar-
ison between follow-up measurements, a paired t-test or
Wilcoxon signed rank test was used for each group.
Subgroup analyses were performed for participants with
hip fractures and for participants with lower cognitive
abilities based on the SPMSQ test. A backward stepwise
multiple linear regression analysis was performed to
study the effects of multiple independent variables on
the studied continuous variables.
Results
We included 44 participants with 27 participants (65%)
having a hip fracture - equally divided over the two
groups. Other fractures included pelvis, humerus, or
femoral shaft fractures. Baseline characteristics showed
no differences between the two groups (see Table 1).
Thirty nine percent of participants (7 in control group,
and 10 in intervention group) were severely undernour-
ished with both serum albumin < 35 g/l and MUAC less
than the 10
th percentile for women over 70 years. Fifty
percent of participants (10 in control group, and 12 in
intervention group) were undernourished with serum
albumin < 35 g/l, and 11% of participants (4 in control
group, and 1 in intervention group) were considered
undernourished with MUAC less than the 10
th percen-
tile for women over 70 years.
During the supplementation of 40 days there were two
participants in the intervention group who withdrew
and after 4 months another participant in this group
withdrew. One participant died during the 4 months.
Compliance of participants in the intervention group
was unclear as no objective measure of this was avail-
able. The research staff mentioned that main reasons
participants reported for being non compliant at home
were that they just did not have the capacity to drink
the supplement because they found it too filling, or it
ended up making them feel nauseated, or they did not
like the taste because it was too sweet.
Diet history of preadmission intakes was obtained
from nine subjects, and the diet history of 40 days after
fractures were obtained from seven subjects. No signifi-
cant differences were found between the control group
and intervention group at base line and 40 days after
fractures in terms of energy and protein intake. Both
the control and intervention subjects decreased their
energy intake and protein intake after their fractures.
Table 2 shows the results of the first follow up after
40 days of supplementation of a high calorie, high pro-
tein nutritional supplement to the intervention group.
After 40 days no differences could be measured between
the two groups in any of the outcomes. Table 2 also
shows the results of the second follow up after 4
months. Again, no differences could be measured
between the two groups in any of the outcomes.
On average, weight declined steadily for both groups
during the intervention period: from 51.1 kg at baseline
to 48.7 kg after 40 days (for n = 22, p = 0.04). After 4
months weight declined slightly further from 47.9 kg to
47.0 kg after 4 months (n = 33, p = 0.18). We found only
2 participants in the control group and 1 in the interven-
tion group with increased weight after 4 months. The
mid upper arm circumference of participants showed no
significant change over time for both groups. Serum
albumin increased in both groups from an average of
31.5 g/l at baseline to 33.5 g/l after 40 days (n = 41, p =
0.035). Grip strength had also increased after 4 months
for both groups, but not significantly. Half of the partici-
pants in both groups were unable to walk without aid
after 40 days and were still unable after 4 months. Gait
velocity increased non- significantly between the 40 days
Table 1 Baseline characteristics of study participants
Control
group
(n = 21)
Intervention
group
(n = 23)
T-test
p-
value
Age (years) (SD) 87.1 (6.2) 83.7 (5.6) 0.07
SPMSQ (mean n of errors
(SD))*
5.1 (3.8) 5.8 (3.7) 0.52
Charlson Index (mean score
(SD))
1.7 (1.8) 1.5 (1.1) 0.67
Weight (kg) (SD)** 50.2 (11.8) 50.4 (6.0) 0.80
BMI (SD) ** 21.5 (4.0) 21.5 (2.8) 0.95
MUAC (cm) (SD)*** 23.6 (2.6) 24.2 (3.1) 0.53
Grip (kg) (SD) 11.0 (5.8) 13.7 (6.8) 0.18
Albumin (g/l) (SD) 31.8 (5.4) 31.1 (5.0) 0.69
Barthel Index (SD)§ 76.6 (21.6) 74.1 (23.4) 0.73
* SPMSQ= Short Portable Mental Status Questionnaire
** based on only 12 participants in control group, 11 participants in
intervention group
*** MUAC= mid upper arm circumference
§ Estimated Barthel Index prior to fracture
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p = 0.098). Mean scores on the Barthel Index dropped
significantly from the estimated pre-injury score to that
after 40 days (n = 41, p < 0.000). No significant change in
the Barthel Index was measured between 40 days and 4
months follow up. We found 3 participants in the control
group with increased Barthel Index (mean = 6.7 points),
and 7 participants in the intervention group (mean 12.3
points) after 4 months.
No differences were measured in initial length of stay
and after re-admission between groups. Median length of
stay in hospital for the control group was 14.0 days (range
5-56). Six participants were readmitted during the study
period for a median of 9.5 days (range 1-128). Median
length of stay for the intervention group in hospital was
23.5 days (range 1-67) and six participants were read-
mitted with a median of 7.0 days (range 1-28). Thirteen
participants suffered at least one complication during the
trial (8 in the control group and 5 in the intervention
group) such as urinary tract infections (6 times), pleural
effusion (2 times), wound infection (1 time), pulmonary
oedema (1 time), delirium (1 time) and a decubitus ulcer
(1 time).
We performed a backward stepwise multiple linear
regression with change in serum albumin, measured
from baseline to 40 days, as dependent variable and age,
hip fracture, baseline MUAC and total length of hospital
stay (within study period) as independent variables.
Total length of hospital stay was independently predic-
tive of the change in serum albumin (R
2 = 0.142, F =
6.39, p = 0.016), meaning that the longer the stay in
hospital the greater the increase in serum albumin.
When change in gait velocity was analyzed as a depen-
dent variable, using similar independent variables, only
greater age was independently predictive of slower gait
velocity (R
2 = 0.127, F = 5.37, p = 0.026).
Subgroup analysis for participants with a hip fracture
again showed no differences between the two groups.
However, grip strength was slightly better in the inter-
vention group than in the control group after 40 days
(15.2 (± 6.2) vs 10.4 (± 6.2), p = 0.056) and the trend
remained after 4 months (15.3 (± 6.0) vs 11.1 (± 6.0), p
= 0.092). For participants with lower cognitive capacity
measured as more than 4 errors in the Short Portable
Mental Status Questionnaire no differences in results
were measured between the two groups.
Discussion
The use of a daily high calorie high protein energy sup-
plement as a simple intervention in a randomized trial
design for older people recovering from a fracture is fea-
sible. However from the results of this small pilot study
no significant benefits were measured for the interven-
tion group in terms of better recovery, less complications,
or better nutritional status after 4 months. Due to the
small sample size and the uncertainty about compliance
for both groups no conclusion can be drawn about these
results.
The inclusion period for this trial was almost three
years to recruit 44 eligible and willing older female parti-
cipants who fulfilled our inclusion criteria of having a
fracture and being undernourished. This is a long recruit-
ment period for such a small number of participants, but
we believe that with more staff and funding it would have
been possible to include many more eligible participants
in a shorter time frame. This could also have helped to
overcome the possible issue regarding uncertainty with
compliance. For future studies it would be valuable to
record the participants overall consumption of the com-
mercial or food supplement, the energy or protein intake
provided and the proportion of nutritional requirement
being met. Not just prescribing or receiving supplements
Table 2 Results after 40 days and after 4 months
Control
group
after 40
days
(n = 21)
Intervention group after 40
days
(n = 23)
Statistical
test†
p-value
Control
group
after 4
months
(n = 21)
Intervention group after 4
months
(n = 23)
Statistical
test†
p-value
Weight (kg) (SD) 48.6 (8.5) 47.7 (7.8) 0.74 46.3 (7.6) 46.9 (7.5) 0.81
BMI (SD) 21.5 (4.0) 20.5 (3.1) 0.39 20.5 (3.8) 20.2 (2.9) 0.81
MUAC (cm) (SD)* 23.7 (3.0) 24.3 (2.8) 0.52 23.3 (3.3) 24.1 (2.7) 0.41
Grip strength (kg) (SD) 12.3 (6.2) 14.7 (5.6) 0.19 12.4 (5.6) 14.8 (5.6) 0.20
Albumin (g/l) (SD) 33.2 (4.4) 33.9 (3.9) 0.62
Gait velocity (m/sec)
(SD)**
0.19 (0.21) 0.20 (0.21) 0.89 0.21 (0.24) 0.27 (0.24) 0.48
Barthel Index (SD) 56.0 (35.0) 66.3 (29.5) 0.31 58.0 (35.8) 60.3 (35.8) 0.84
* MUAC= mid upper arm circumference
** Gait velocity measured as how many seconds to finish 2.44 m walk, with those unable to walk calculated as 0 m/sec.
† T-test or Mann-Whitney Test between control and intervention group.
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tional goals is the critical factor.
For the control group it was the policy in the hospital
to provide the patients with high protein milk, contain-
ing half the energy and protein of the intervention
group. Also, for this group of patients it is uncertain to
what extent they complied with the policy of the hospi-
tal. As the weight in both groups of patients declined
and continued to decline future studies not only need to
know exactly what amount of supplement was actually
used, but also what the diet was during both hospital
stay and after discharge. A compliance officer that
would record nutritional intake for both groups is
recommended for future studies.
One of our inclusion criteria on nutritional status was
based on the study by Falciglia et al. [18]. She calculated
reference norms for the mid upper arm circumference
based on older people living in the USA. It is possible
that the Australian participants in this study appeared
more undernourished compared to these US norms
t h a ni ft h e yh a db e e nc o m p a r e dt oad i f f e r e n ts e to f
reference norms. There are various ways to define and
to assess malnutrition as described by Milne et al. 2009
in their Cochrane Review [2]. We used the definition by
Constans et al. and included 50% of participants based
on reduced Albumin alone (with MUAC > 10th percen-
tile for age and gender) [11]. Future studies using differ-
ent definitions of malnutrition may find different effects
of oral supplements. During the first 40 days when the
majority of patients were still in hospital, serum albumin
increased significantly in association with the high cal-
orie, high protein nutritional supplement and/or the
high protein milk provided. Nevertheless it appeared
that weight decreased significantly during that same per-
iod. After 4 months, when the majority of participants
were no longer in hospital, a further decline in weight
was measured. This can in part be attributed to patients
not being compliant with the supplements after dis-
charge, or because the supplement provision was not
adequate to address the actual requirements. Those
patients with cognitive impairment who were discharged
to nursing homes probably faced similar difficulties.
Both types of oral supplements used in this study were
considered reasonably palatable by the research staff.
However, during the intervention period a few com-
plaints were received that participants actually did not
like to drink the supplement because of its taste or
b e c a u s ei tw a st o of i l l i n g .A si tm a yb ei m p o s s i b l et o
find an oral supplement that suits everybody, an alterna-
tive could be to use the strategy suggested by Miller et
al. [21]. They provided oral supplements with 6 types of
flavour and in different amounts depending on the
energy requirement of the patient in a similar trial. On
the other hand, this strategy resulted in a median
compliance of 65% only, and it may be too impractical
for hospitals to individualize the supplement to this
extent.
The recent updated Cochrane Review on nutritional
supplementation concluded that oral supplementation
has no proven effect on post hip fracture mortality [6].
The authors of that review also concluded that oral sup-
plementation may possibly reduce ‘unfavourable out-
comes’ (death or complications) although there were no
statistically significant effects reported. Consistent with
these results, in this small pilot study no difference in
number of complications could be measured between the
two groups.
The majority of included studies in the Cochrane Review
compared high protein supplement with a control situa-
tion, whereas in this study we compared a high protein
and high energy supplement with a high protein supple-
ment while participants were hospitalised. The difference
in percentage protein between the supplement Sustagen
Hospital Plus and the high protein milk is only 0.2 g per
100 ml and between the supplement Novasource 2.0 and
the high protein milk 1.7 g per 100 ml. Therefore, in this
trial the effect from the intervention would mostly be a
result from the high energy of the supplement (a combina-
tion of the carbohydrates andf a t )a n dt h ev i t a m i n sa n d
minerals. The study by Botella-Carretero et al. who tested
the effect of similar types of supplement as used in this
study on normally nourished or mildly undernourished
patients with a hip fracture also showed little difference in
effect on the nutritional status [5]. However, that study
did find that for those patients who underwent a surgical
treatment and/or who had a longer hospital stay, both
supplements could have a positive effect on serum albu-
min measured at discharge. In line with that study, we
found that total length of hospital stay also had a positive
effect on serum albumin after four months. Although it
seems likely that during the hospital stay compliance with
the use of prescribed oral supplements was higher than
after discharge, this effect may also be a result of the stan-
dard procedure in hospital of providing high protein milk.
Strength of this pilot study is the randomized con-
trolled design and the follow up time to measure the
effect of oral supplementation for a longer time than
just during hospital stay. The small number of partici-
pants due to the pilot character of this study may have
resulted in a lack of effect in any of the outcome mea-
sures. Although research so far is unclear whether oral
supplements reduce normal dietary intake, it could have
been useful to analyse this information as well [2,21].
For future studies, we recommend that a similar study
design is used with more participants and with more
information about actual compliance and other dietary
intake. In this study, standard procedure for older peo-
ple admitted to this particular hospital was to provide
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diet. Future trials need to take into account that general
policies of hospitals may now include supplementation
as standard for older people recovering from a fracture.
This may complicate performing a randomized trial test-
ing particularly the effect of oral supplementation in
these settings. Based on trends in this pilot study it may
r e q u i r eas m a l l e rs a m p l es i z et od e t e c tad i f f e r e n c ei n
functioning than an impact on nutritional variables (see
Table 2).
Conclusion
Performing a randomized trial in a hospital setting to
test the effect of an oral high energy high protein sup-
plement for older people suffering from a fracture is fea-
sible. No conclusion can be drawn about the effect of
nutritional supplementation for this type of patients due
to the limited number of participants and incomplete
adherence with use of the supplements. Further rando-
mized studies appropriately sized and with rigorous con-
trols of the intervention are needed.
Additional material
Additional File 1: Appendix 1. Nutrients Value for supplements.
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